Cibc World Markets Corp Biotechnology

Cibc World Markets Corp

$14.8 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AUPH Aurinia Pharmaceuticals Inc.	$1.75B	$122,000 0.0% of portfolio	14,513	Q2 2025 Reduced 51.28%
NTLA Intellia Therapeutics, Inc.	$943M	$119,000 0.0% of portfolio	12,709	Q2 2025 Reduced 43.56%
NVAX Novavax Inc	$656M	$116,000 0.0% of portfolio	18,449	Q2 2025 Reduced 46.06%
ARDX Ardelyx, Inc.	$1B	$113,000 0.0% of portfolio	29,076	Q2 2025 Reduced 44.3%
AKBA Akebia Therapeutics, Inc.	$524M	$112,000 0.0% of portfolio	30,804	Q2 2025 Reduced 35.89%
GERN Geron Corp	$480M	$105,000 0.0% of portfolio	74,800	Q2 2025 Reduced 43.0%
SNDX Syndax Pharmaceuticals Inc	$896M	$98,000 0.0% of portfolio	10,499	Q2 2025 Reduced 42.42%
AVXL Anavex Life Sciences Corp.	$709M	$94,000 0.0% of portfolio	10,300	Q2 2025 Reduced 38.14%
COGT Cogent Biosciences, Inc.	$816M	$93,000 0.0% of portfolio	13,081	Q2 2025 Reduced 35.75%
MDXG Mimedx Group, Inc.	$792M	$89,000 0.0% of portfolio	14,582	Q2 2025 Reduced 44.58%
WVE Wave Life Sciences Ltd.	$600M	$89,000 0.0% of portfolio	13,811	Q2 2025 Reduced 35.53%
XERS Xeris Biopharma Holdings, Inc.	$999M	$86,000 0.0% of portfolio	18,473	Q2 2025 Reduced 40.63%
IBRX Immunity Bio, Inc.	$1.1B	$74,000 0.0% of portfolio	28,343	Q2 2025 Reduced 16.42%
NUVB Nuvation Bio Inc.	$684M	$59,000 0.0% of portfolio	30,750	Q2 2025 Reduced 23.56%
ABUS Arbutus Biopharma Corp	$679M	$57,000 0.0% of portfolio	18,653	Q2 2025 Reduced 42.46%
RLAY Relay Therapeutics, Inc.	$546M	$56,000 0.0% of portfolio	16,316	Q2 2025 Reduced 41.56%
VIR Vir Biotechnology, Inc.	$637M	$55,000 0.0% of portfolio	10,974	Q2 2025 Reduced 45.52%
IOVA Iovance Biotherapeutics, Inc.	$350M	$54,000 0.0% of portfolio	31,589	Q2 2025 Reduced 48.16%
TSHA Taysha Gene Therapies, Inc.	$145M	$47,000 0.0% of portfolio	20,417	Q2 2025 Reduced 47.51%
SANA Sana Biotechnology, Inc.	$614M	$44,000 0.0% of portfolio	16,439	Q2 2025 Reduced 43.96%
HRTX Heron Therapeutics, Inc.	$147M	$39,000 0.0% of portfolio	18,848	Q2 2025 Reduced 27.65%
MRVI Maravai Lifesciences Holdings, Inc.	$370M	$36,000 0.0% of portfolio	15,040	Q2 2025 Reduced 38.63%
SVRA Savara Inc	$414M	$35,000 0.0% of portfolio	15,589	Q2 2025 Reduced 41.67%
ABSI Absci Corp	$243M	$34,000 0.0% of portfolio	13,447	Q2 2025 Reduced 25.29%
QSI Quantum Si Inc	$150M	$34,000 0.0% of portfolio	17,379	Q2 2025 Reduced 34.83%
HUMA Humacyte, Inc.	$158M	$32,000 0.0% of portfolio	15,443	Q2 2025 Reduced 23.07%
CMPX Compass Therapeutics, Inc.	$372M	$29,000 0.0% of portfolio	11,294	Q2 2025 Reduced 50.09%
ANNX Annexon, Inc.	$124M	$28,000 0.0% of portfolio	11,799	Q2 2025 Reduced 45.54%
GOSS Gossamer Bio, Inc.	$299M	$28,000 0.0% of portfolio	23,401	Q2 2025 New
ERAS Erasca, Inc.	$195M	$27,000 0.0% of portfolio	21,388	Q2 2025 Reduced 47.56%
PGEN Precigen, Inc.	$747M	$26,000 0.0% of portfolio	18,484	Q2 2025 Reduced 38.18%
RCKT Rocket Pharmaceuticals, Inc.	$244M	$25,000 0.0% of portfolio	10,334	Q2 2025 Reduced 39.57%
SLS Sellas Life Sciences Group, Inc.	$34.5M	$25,000 0.0% of portfolio	11,759	Q2 2025 New
CDXS Codexis, Inc.	$160M	$24,000 0.0% of portfolio	10,088	Q2 2025 Reduced 43.57%
EDIT Editas Medicine, Inc.	$184M	$22,000 0.0% of portfolio	10,399	Q2 2025 Reduced 43.45%
ALLO Allogene Therapeutics, Inc.	$163M	$21,000 0.0% of portfolio	18,682	Q2 2025 Reduced 34.41%
LIFE A Tyr Pharma Inc	$53.2M	$19,000 0.0% of portfolio	10,718	Q2 2025 New
FATE Fate Therapeutics Inc	$92.2M	$15,000 0.0% of portfolio	13,400	Q2 2025 Reduced 39.68%
CHRS Coherus Bio Sciences, Inc.	$98.7M	$9,000 0.0% of portfolio	13,068	Q2 2025 Reduced 47.6%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.